Data / Form D filings / Tellus Therapeutics, Inc.
Tellus Therapeutics, Inc.: Form D filings
Tellus Therapeutics, Inc., a pharmaceuticals company in Durham, NC, filed 3 Form D notices with the SEC between 2019 and 2023. The latest, on February 21, 2023, reports $16 million sold of a $35 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8 DAVIS DRIVE, SUITE 220, Durham, NC, 27709
- Phone
- (919) 491-4995
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1766205
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | New notice | $35,000,000 | $15,999,999 | $19,000,001 | 1 | Nov 17, 2022 | sec.gov |
| Jul 16, 2021 | New notice | $2,000,000 | $2,000,000 | 1 | May 10, 2021 | sec.gov | |
| Jan 31, 2019 | New notice | $75,000 | $75,000 | 1 | Jan 21, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chris J. Garabedian | Director | |
| Jason E. Kralic | Executive Officer, Director | |
| Eric J. Benner | Executive Officer, Director | |
| Fred J. Callori | Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Feb 20, 2023 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Tellus Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.